← All trials
NCT02076594
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2013
- Primary completion
- Jun 1, 2019
- Completion date
- Dec 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteLead sponsor
- Luigi Sacco University HospitalOverall official - principal investigator
- AUSL di Piacenza, Oncologia MedicaOverall official - principal investigator
- ASUR Zona 6 di Fabriano, OncologiaOverall official - principal investigator
- Istituto Tumori di Bari, Oncologia MedicaOverall official - principal investigator
- A.O. Ospedale Maggiore di LodiOverall official - principal investigator
- A.O. Ospedale San Carlo di PotenzaOverall official - principal investigator
- A.O. Ospedale Versilia di CamaioreOverall official - principal investigator
- A.O. TREVIGLIO-CARAVAGGIOOverall official - principal investigator
- A.O. di PescaraOverall official - principal investigator
- OSPEDALE POLICLINICO G.B. ROSSIOverall official - principal investigator
- Ospedale Civile di SondrioOverall official - principal investigator
- Ospedale Fatebenefratelli di RomaOverall official - principal investigator
- Ospedale Generale Provinciale di SaronnoOverall official - principal investigator
- Ospedale San Vincenzo TaorminaOverall official - principal investigator
- Ospedale degli Infermi di BiellaOverall official - principal investigator
- Ospedale di CarpiOverall official - principal investigator
- Ospedale di CircoloOverall official - principal investigator
- Presidio Socio Sanitario Territoriale di GorgonzolaOverall official - principal investigator
- Ospedale Sacro CuoreOverall official - principal investigator
- Azienda Sanitaria dell'Alto AdigeOverall official - principal investigator
- University of MilanOverall official - principal investigator
- University of Modena and Reggio EmiliaOverall official - principal investigator
- University of CagliariOverall official - principal investigator
- Marche Polytechnic UniversityOverall official - principal investigator
- University of Roma La SapienzaOverall official - principal investigator
- University of BresciaStudy director
- A. O. Sant'Anna di ComoOverall official - principal investigator
- Ospedale Misericordia e Dolce, PratoOverall official - principal investigator
- Regione LombardiaCollaborator
- Vita-Salute University of Milano. ItalyOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.